Anticoagulant combination with vitamin supplement

This page covers all Anticoagulant combination with vitamin supplement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor Xa, Thrombin (LMWH component); Dihydrofolate reductase (folic acid component).

Targets

Factor Xa, Thrombin (LMWH component); Dihydrofolate reductase (folic acid component)

Marketed (1)

• LMWH+Folic acid · Omar Mamdouh Shaaban · Cardiovascular / Hematology
  This combination product uses low-molecular-weight heparin (LMWH) to prevent blood clots and folic acid to support cellular function and reduce homocysteine levels.

Patent intelligence

• anticoagulant combination with vitamin supplement patent landscape — aggregated cliff calendar, attackable patents, originator estates